Testosterone
Brand name: Testosterone
Rank #341 of 500 drugs by total cost
$30.4M
Total Cost
131,549
Total Claims
$30.4M
Total Cost
5,934
Prescribers
$231
Cost per Claim
9,042
Beneficiaries
175,037
30-Day Fills
$5,119
Avg Cost/Provider
22
Avg Claims/Provider
About Testosterone
Testosterone (sold as Testosterone) was prescribed 131,549 times by 5,934 Medicare Part D providers in 2023, costing the program $30.4M. At $231 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 338 | Midodrine Hcl (Midodrine Hcl) | $30.9M | 383,390 |
| 339 | Sarilumab (Kevzara) | $30.5M | 6,822 |
| 340 | Dabrafenib Mesylate (Tafinlar) | $30.4M | 2,377 |
| 341 | Testosterone (Testosterone) | $30.4M | 131,549 |
| 342 | Hydroxyzine Hcl (Hydroxyzine Hcl) | $30.2M | 1,474,936 |
| 343 | Irbesartan (Irbesartan) | $30.1M | 869,928 |
| 344 | Amiodarone Hcl (Amiodarone Hcl) | $29.9M | 1,007,679 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology